2021
DOI: 10.1016/j.drugalcdep.2021.108772
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of US states’ adoption of naloxone access laws, 2001–2017

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 57 publications
0
3
0
Order By: Relevance
“…Key informants discussed themes around the intersection of rurality and stigma. KIs described rural areas of their state that were conservative and as a result less accepting of opioid use and treatment ( Bohler et al, 2023 , Des Jarlais et al, 2015 , Green et al, 2020 , Bohler et al, 2021 ). They also described the lack of privacy available in pharmacies in areas where resources come from a common source (such as groceries and medications in one store) and describe this as a concern across other health conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Key informants discussed themes around the intersection of rurality and stigma. KIs described rural areas of their state that were conservative and as a result less accepting of opioid use and treatment ( Bohler et al, 2023 , Des Jarlais et al, 2015 , Green et al, 2020 , Bohler et al, 2021 ). They also described the lack of privacy available in pharmacies in areas where resources come from a common source (such as groceries and medications in one store) and describe this as a concern across other health conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Given that the impacts of legalization on the social acceptability of treatment-seeking behaviors are still poorly understood [46], it is difficult to surmise whether changes in the legal status of cannabis across states and over the duration of the study may have had a distorting impact on the results. Another key policy area is the state adoption of naloxone access laws (NAL), which increased rapidly from 2013 onward [47]. By 2020, all 50 states and the District of Columbia had some form of NAL in place, although the laws varied significantly across states [48].…”
Section: Limitationsmentioning
confidence: 99%
“…While these laws vary by state, they typically include one or more of the following provisions: (1) allowing for non-patient-specific prescriptions through a standing or protocol order; (2) granting prescriptive authority to pharmacists; (3) permitting third-party prescribing that authorizes the prescribing and dispensing of naloxone to people who are not at-risk of overdose themselves, but are likely to witness an overdose and administer naloxone to others; (4) mandatory co-prescribing to persons at high risk for overdose, such as those dispensed high doses of prescription opioids or with a history of substance use disorder; or 5) removal of professional, civil, and/or criminal liability for persons administering, prescribing, or dispensing naloxone ( Davis and Carr, 2015 , 2017 ). All 50 states had implemented NALs as of 2017, with rapid adoption beginning in 2013 ( Bohler et al, 2021 ). There is rigorous evidence suggesting NALs increase naloxone availability in communities with mixed evidence of their impact on opioid-related mortality ( Mauri et al, 2020 ; Smart et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%